相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-throughput methylation profiling by MCA coupled to CpG island microarray
Marcos R. H. Estecio et al.
GENOME RESEARCH (2007)
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
Shuchi Agrawal et al.
BLOOD (2007)
RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis
Yanis A. Boumber et al.
CANCER RESEARCH (2007)
Changes in DNA methylation patterns in subjects exposed to low-dose benzene
Valentina Bollati et al.
CANCER RESEARCH (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
A. Scardocci et al.
BRITISH JOURNAL OF CANCER (2006)
CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia
Jose Roman-Gomez et al.
CLINICAL CANCER RESEARCH (2006)
Silencing of bidirectional promoters by DNA methylation in tumorigenesis
Jingmin Shu et al.
CANCER RESEARCH (2006)
Promoter hypermethylation of the retinoic acid receptor β2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFβ-MYH11 fusion transcripts
A Rethmeier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia
J Jelinek et al.
BLOOD (2005)
Epigenetic changes in solid and hematopoietic tumors
M Toyota et al.
SEMINARS IN ONCOLOGY (2005)
被撤回的出版物: Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis (Retracted article. See vol. 31, pg. 979, 2013)
J Roman-Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
JPJ Issa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Methylation silencing of the Apaf-1 gene in acute leukemia
Y Furukawa et al.
MOLECULAR CANCER RESEARCH (2005)
Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours
M Murai et al.
BRITISH JOURNAL OF CANCER (2005)
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
L Yu et al.
NATURE GENETICS (2005)
Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers
EM Youssef et al.
CANCER RESEARCH (2004)
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements -: art. no. e38
AS Yang et al.
NUCLEIC ACIDS RESEARCH (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells
ZJ Liu et al.
FEBS LETTERS (2004)
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia
LL Shen et al.
BLOOD (2003)
Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa
J Roman-Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
M Daskalakis et al.
BLOOD (2002)
Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors
T Kikuchi et al.
ONCOGENE (2002)
分享论文
